Austin, Texas-based OsteoCentric Technologies, Inc. has obtained $30 million in growth capital to introduce new products at OsteoCentric Trauma, LLC and expand its orthopedic and dental product lines.
OsteoCentric Technologies Obtains $30M in Growth Capital
1 min read Premium comments
Secondary#osteocentric#mechanicalintegration
The funding round was led by Dallas, Texas-based OnPoint Advisors, LLC and Granby, Connecticut-based Squadron Capital LLC. OnPoint Advisors supports capital formation and private investment. Squadron Capital is a private investment firm.
Founded in 2015, OsteoCentric Technologies markets what it refers to as Unifi Mechanical Integration (UnifiMI™) technology which was developed to address implant instability. Employing a proprietary method, OsteoCentric secures an implant to bone with mechanical integration. According to the company, “UnifiMI mechanically integrates with bone to provide instant and lasting multi-axial stability and load sharing in normal, compromised and osteoporotic bone.”
In the company’s own words, UnifiMI both prepares and preserves bone. Once implanted, UnifiMI preserves bone via its patented thread geometries. Those thread geometries, say OsteoCentric, minimize “outward forces applied to the mechanically integrated (MI) bone.”
The company plans to use funding to expand application of UnifiMI across multiple applications including spine, joint reconstruction, and extremities.
OsteoCentric Technologies Founder and CEO Eric Brown said, “Orthopedic manufacturers have developed amazing implants over the years, but their methods for securing the implants to bone have remained largely unchanged for decades. Current methods can damage the bone, delay the patient’s return to motion, and are not designed to instantly interlock with the bone to optimize implant stability.”
Brown continued, “OsteoCentric invented a less invasive method of securing implants to bone which is designed to preserve the bone and facilitate the patient’s return to motion. Our proprietary thread geometry is capable of instantly interlocking with the bone to optimize acute and long-term implant stability. Based on the widespread adoption of UnifiMI products by key opinion leader surgeons, mechanically integrated implants are rapidly setting a new performance standard for instantly securing implants to normal and compromised bone.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.